Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODIn-AF: Dabigatran for Prevention of Silent Cerebral Thromboembolism After Pulmonary Vein Isolation
NCT02067182Phase 4Completed
- Start
- Aug 2015
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dabigatran in Atrial fibrillation (AFib), cardioembolic stroke. Started Aug 2015; status: completed.
02
Drugs
dabigatran
03
Conditions
Atrial fibrillation (AFib)cardioembolic stroke
Beyond the preview
Go deeper on NCT02067182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02067182.